How to Buy Diamedica Therapeutics Stock
Diamedica Therapeutics Inc
DiaMedica Therapeutics Inc. , a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
Diamedica Therapeutics stock last closed at $2.60, up 9.7% from the previous day, and has increased 60.49% in one year. It has overperformed other stocks in the Biotechnology industry by 0.86 percentage points. Diamedica Therapeutics stock is currently +73.33% from its 52-week low of $1.50, and -45.26% from its 52-week high of $4.75.
There are currently 37.96M shares of DMAC outstanding. The market value of DMAC is $98.69M. In the past 24 hours, 40,806 DMAC shares were traded.
How to Buy Diamedica Therapeutics Stock
Wondering how to invest in Diamedica Therapeutics stock? Here's how.
- Choose where to buy Diamedica Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Diamedica Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your payment method and add your information.
- Analyze Diamedica Therapeutics stock: The Diamedica Therapeutics ticker symbol is DMAC. Is Diamedica Therapeutics stock a good investment? Should you buy shares of DMAC? How do DMAC's underlying business fundamentals look? Do top analysts think Diamedica Therapeutics is a good buy? Why has DMAC's stock price moved recently? (Hint: Our stock research tools can help you understand if DMAC is a good stock to buy).
- Make your DMAC trade: Decide if you will purchase DMAC shares at the current market price or use a limit order to buy DMAC shares at a particular price.
- Get the latest scoop on your investment in DMAC: Create a watchlist to get live updates on your new investment in Diamedica Therapeutics stock.
Step 1: Choose where to buy Diamedica Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy DMAC shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal information so you are able to invest in DMAC stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on a good stock buying app, you need to deposit funds:
Check out the walkthrough below if you need help depositing funds into your investment account.
Step 4: Analyze Diamedica Therapeutics stock
Once you have figured out the best place to buy Diamedica Therapeutics stock, it's crucial to evaluate their stock before you invest, so you actually wrap your head around the risk as well as the upside.
Diamedica Therapeutics Metrics
DMAC Zen Score
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on DMAC's stock page.
How is DMAC stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge DMAC's intrinsic value.
Using relative valuations ratios:
- DMAC may be undervalued based on its P/B ratio of 1.93x, relative to Biotechnology industry P/B ratio of 5.83x
You can access additional valuation analysis on DMAC's stock here.
A quick look at DMAC Financials
Positive Financial Indicators:
- DMAC has $52.90M in cash and short term investments. This is enough to cover its annual cash burn of $18.75M.
- Total DMAC debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the DMAC balance sheet.
- There are more short-term assets than short-term liabilities on the DMAC balance sheet.
- DMAC has a low debt to equity ratio of 0.06.
- DMAC has cash burn of 18752000. It has enough cash and short-term investments to cover this for at least one year.
Is it a good time to buy Diamedica Therapeutics stock, according to analysts?
Out of 2 Equities analysts who research DMAC, the consensus analyst rating on Diamedica Therapeutics is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Diamedica Therapeutics stock forecast page.
DMAC Momentum
How are DMAC Revenues/Earnings doing?
Last year, DMAC revenue was $0.00. Over the last five year, DMAC's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 29.02%.
Dig into DMAC's earnings and revenue performance here.
Are DMAC executives and large shareholders buying or selling the stock?
In the past year, insiders at DMAC have bought more shares than they have sold.
Randall Michael Giuffre, Director of DMAC, was the latest DMAC insider to buy. They bought $53,748.80 worth of DMAC shares on Jan 2, 2024.
Get more info about who owns DMAC shares here.
Can I rely on DMAC as an income stream?
No, Diamedica Therapeutics doesn't provide an income stream by paying out dividends.
DMAC Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your DMAC trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, use a limit order.
Click the Open Trade button and your broker will place the order.
If you require more help buying stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in DMAC
Now that you own some DMAC shares, you'll want to keep up with your new investment.
Start a watchlist to get notified of the latest news about your DMAC stock.
DMAC Feed
How to Buy Stock in Diamedica Therapeutics
To reiterate, here are the 6 steps to buy stock in Diamedica Therapeutics:
- Choose where to buy Diamedica Therapeutics stock
- Sign up for a brokerage account
- Fund your investment account
- Analyze Diamedica Therapeutics stock
- Make your DMAC trade
- Get the latest scoop on your investment in DMAC
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get updates on your new investment in Diamedica Therapeutics, click below.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.